Tumor Biology

, Volume 35, Issue 9, pp 8991–8998 | Cite as

In vitro antileukaemic activity of extracts from Daphne gnidium leaves against sensitive and multidrug resistant K562/R7 cells

  • Fadwa Chaabane
  • Mounira Krifa
  • Eva Matera
  • Amira Loussaeif
  • Marie-Geneviève Dijoux-Franca
  • Kamel Ghedira
  • Charles Dumontet
  • Leila Chekir-GhediraEmail author
Research Article


The antiproliferative potential of extracts of Daphne gnidium L. (Thymelaeaceae) on K562 cells was assessed, and the capacity of these extracts to disturb the cell cycle of K562 cells and to inhibit human P-glycoprotein was evaluated. The antiproliferative activity was evaluated using the MTT assay. The cell cycle analysis and the inhibition of P-glycoprotein were tested by flow cytometry. All the tested extracts exhibited significant anti-proliferative effects. Ethyl acetate extract has the strongest cytotoxic effect with an IC50 of 18.5 μg/ml. Furthermore, cell cycle analysis revealed that cells treated with chloroform, butanol and aqueous extracts were arrested predominantly in G2-M phase. Butanol extract was the most active extract. Percentage of cells arrested in G2-M was 34 %, 36.67 % and 42.63 % respectively, after treatment with 25, 75 and 100 μg/ml of the extract, versus 19 % in the cells treated with the vehicle solvent. In addition, chloroform extract had the ability to inhibit human P-glycoprotein-mediated daunorubicin in K562/R7 leukaemic cells in a dose-dependent manner compared to the positive control, cyclosporin A. These findings demonstrate that extracts from D. gnidium leaves have antileukaemic activity by perturbing the cell cycle of K562 and inhibiting human P-glycoprotein in K562/R7 cell line.


Daphne gnidium Modulation of antitumour drug resistance Anticancer therapy Polyphenols 



Part of this work was conducted at the University of Lyon, thanks to a scholarship of the Region Rhone-Alpes (MIRA scholarship).

Conflicts of interest



  1. 1.
    Hollman PCH, Hertog MGL, Katan MB. Analysis and health effects of flavonoids. Food Chem. 1996;57:43–6.CrossRefGoogle Scholar
  2. 2.
    Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total phenolics content in selected fruits, vegetables, and grain products. J Agric Food Chem. 1998;46:4113–7.CrossRefGoogle Scholar
  3. 3.
    Hannum SM. Potential impact of strawberries on human health a review of the science. Crit Rev Sci Nutr. 2004;44:1–17.CrossRefGoogle Scholar
  4. 4.
    Maas JL, Galletta GJ. Ellagic acid, an anticarcinogen in fruits, especially in strawberries: a review. Hort Sci. 1991;26:10–4.Google Scholar
  5. 5.
    Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427.CrossRefPubMedGoogle Scholar
  6. 6.
    Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92:1295–302.CrossRefPubMedGoogle Scholar
  7. 7.
    Versantvoort CH, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM, Lankelma J, et al. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer. 1993;68:939–46.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Limtrakul P, Khantamat O, Pintha K. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemother Pharmacol. 2004;54:525–30.CrossRefPubMedGoogle Scholar
  9. 9.
    Kupchan SM, Baxter R. Mezerein: Antileukemic principle isolated from Daphne mezereum L. Science. 1975;187:652–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Kupchan SM, Shizuri Y, Sumner WC, Haynes HR, Leighton AP, Sickles BR. Isolation and structural elucidation of new potent antileukemic diterpenoid esters from Gnidia species. J Org Chem. 1976;41:3850–3.CrossRefPubMedGoogle Scholar
  11. 11.
    Chaouki W, Leger DD, Liagre B, Cherrah Y, Beneytout JL, Hmamouchi M. Roots of Daphne gnidium L. inhibit cell proliferation and induce apoptosis in the human breast cancer cell line MCF-7. Pharmazie. 2009;64:542–6.PubMedGoogle Scholar
  12. 12.
    Jouglard J. Intoxications d'origine végétale Encycl Med- Chir, Paris, Intoxications, 2-16065 A-10 et A-20 1977.Google Scholar
  13. 13.
    Bellakhdar J. La pharmacopée marocaine traditionnelle: médecine arabe ancienne et savoirs populaires. France: Ibis Press; 1997.Google Scholar
  14. 14.
    Pottier-Alapetite G. Flore de la Tunisia: Angiospermes, Dicotyledones, Apetales, Dialypetales. Tunisia: Ministère de L’Enseignement Supérieur et de la Recherche Scientifique et Ministère de l’Agriculture 1979.Google Scholar
  15. 15.
    Yuan VY, Bone DE, Carrington F. Antioxidant activity of dulse (Palmaria palmata) extract evaluated in vitro. Food Chem. 2005;91:485–94.CrossRefGoogle Scholar
  16. 16.
    Kumar A, Chattopadhyay S. DNA damage protecting activity and antioxidant potential of pudina extract. Food Chem. 2006;100:1377–84.CrossRefGoogle Scholar
  17. 17.
    Raju J, Bird RP. Diosgenin, a naturally occurring steroid saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett. 2007;255:194–204.CrossRefPubMedGoogle Scholar
  18. 18.
    Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 1999;64:555–9.CrossRefGoogle Scholar
  19. 19.
    Twentyman PR, Fox NE, Rees JK. Chemosensitivity testing of fresh leukaemic cells using the MTT colourimetric assay. Br J Haematol. 1989;71:19–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Comte G, Daskiewicz JB, Bayet C, Conseil G, Viornery-Vanier A, Dumontet C, et al. C-isoprenylation of flavonoids enhances binding affinity towards P-glycoprotein and modulation of cancer cell chemoresistance. Med Chem. 2001;44:763–8.CrossRefGoogle Scholar
  21. 21.
    Li X, Tong W, Bornmann W, Schwartz GK. Huanglian Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol. 2000;58:1287–93.PubMedGoogle Scholar
  22. 22.
    Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, et al. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 1994;54:448–54.PubMedGoogle Scholar
  23. 23.
    Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for Phase I and II trials. Cancer Invest. 2002;20:1069–79.CrossRefPubMedGoogle Scholar
  24. 24.
    Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J Nutr Biochem. 2008;19:347–61.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr. 1996;16:33–50.CrossRefPubMedGoogle Scholar
  26. 26.
    Menendez JA, Vazquez-Martin A, Colomer R, Brunet J, Carrasco-Pancorbo A, Garcia-Villalba R, et al. Olive oil’s bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells. BMC Cancer. 2007;7:80.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Rao YK, Madamanchi G, Shih-Hua F. Yew-Min Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: a comparative study. Food Chem Toxicol. 2007;45:1770–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Boubaker J, Bhouri W, Ben Sghaier M, Ghedira K, Dijoux Franca MG, Chekir-Ghedira L. Ethyl acetate extract and its major constituent, isorhamnetin 3-O-rutinoside, from Nitraria retusa leaves, promote apoptosis of human myelogenous erythroleukaemia cells. Cell Prolif. 2011;10:1365–2184.Google Scholar
  29. 29.
    Abdelwahed A, Bouhlel I, Skandrani I, Valenti K, Kadri M, Guiraud P, et al. Study of antimutagenic and antioxidant activities of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Confirmation by microarray expression profiling. Chem Biol Interact. 2007;165:1–13.CrossRefPubMedGoogle Scholar
  30. 30.
    Hirano T, Gotoh M, Oka K. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci. 1994;55:1061–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Kuntz S, Wenzel U, Daniel H. Comparative analysis of effects of flavonoids on proliferation, antiproliferativity and apoptosis in human colon cancer cell lines. Eur J Nutr. 1999;38:133–42.CrossRefPubMedGoogle Scholar
  32. 32.
    Narayanann AA, Geoffroy O, Willingham MC, Re GG, Nixon DW. p35/p21 (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett. 1999;136:215–21.CrossRefGoogle Scholar
  33. 33.
    Kang TB, Liang NC. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol. 1997;54:1013–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Lepley DM, Li B, Birt DF, Pelling JC. The chemopreventive flavonoid apigenin induces G2-M arrest in keratinocytes. Carcinogenesis. 1996;17:2367–75.CrossRefPubMedGoogle Scholar
  35. 35.
    Hadfield JA, Ducki S, Hirst N, McGown AT. Tubulin and microtubules as targets for anticancer drugs. Progress Cell Cycle Res. 2003;44:309–25.Google Scholar
  36. 36.
    Yuan SY, Lin CC, Hsu SL, Cheng YW, Wu JH, Cheng CL, et al. Leaf Extracts of Calocedrus formosana (Florin) Induce G2/M cell cycle arrest and apoptosis in human bladder cancer cells. Evid Based Complement Alternat Med. 2011;2011:380923.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Checchi PM, Nettles JH, Zhou J, Snyder JP, Joshi HC. Microtubule-interacting drugs for cancer treatment. Trends Pharmacol Sci. 2003;24:361–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Li W, Lam MS, Birkeland A, Riffel A, Montana L, Sullivan ME. Post JM.) Cell-based assays for profiling activity and safety properties of cancer drugs. J Pharmacol Toxicol Methods. 2006;54:313–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Bae SJ, Choi YH. Methanol Extract of the seaweed Gloiopeltis furcata induces G2/M arrest and inhibits cyclooxygenase-2 activity in human hepatocarcinoma HepG2 cells. Phytother Res. 2007;21:52–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Leslie EM, Deeley RG, Cole SPC. Multidrug resistance proteins in toxicology: role of P-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005;204:216–37.CrossRefPubMedGoogle Scholar
  41. 41.
    Lehnert M. Chemotherapy resistance in breast cancer. Anticancer Res. 1998;18:2225–6.PubMedGoogle Scholar
  42. 42.
    Orlowski S, Mir LM, Belehradek Jr J, Garrigos M. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J. 1996;317:515–22.PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Kitagawa S, Nabekura T, Takahashi T, Nakamura Y, Sakamoto H, Tano H, et al. Structure–activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull. 2005;28:2274–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br J Pharmacol. 1999;128:403–11.PubMedCentralCrossRefPubMedGoogle Scholar
  45. 45.
    Fernandes J, Castilho RO, da Costa MR, Wagner-Souza K, Coelho Kaplan MA, Gattass CR. Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett. 2003;20:165–9.CrossRefGoogle Scholar
  46. 46.
    Chi-Keung W, Guo-Yuan Z, Xiao-Ling S, Apurba C, Saibal D, Wang-Fun F. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells. Biochem Pharmacol. 2006;72:824–37.CrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Fadwa Chaabane
    • 1
  • Mounira Krifa
    • 1
  • Eva Matera
    • 2
  • Amira Loussaeif
    • 1
  • Marie-Geneviève Dijoux-Franca
    • 3
  • Kamel Ghedira
    • 1
  • Charles Dumontet
    • 2
  • Leila Chekir-Ghedira
    • 1
    • 4
    • 5
    Email author
  1. 1.Unité de Substances Naturelles Bioactives et Biotechnologie UR12ES12, Faculté de Pharmacie de MonastirUniversité de MonastirMonastirTunisie
  2. 2.Laboratoire de Cytologie Analytique (Inserm U590)Faculté de MédecineLyon cedex 08France
  3. 3.Equipe Multirésistance Environnementale et Efflux Bactérien, Centre d’Etude des Substances NaturellesUMR 5557 CNRS/Université Lyon1LyonFrance
  4. 4.Laboratoire de Biologie Cellulaire et MoléculaireFaculté de Médecine DentaireMonastirTunisie
  5. 5.Faculté de Médecine dentaireMonastirTunisie

Personalised recommendations